Cargando…
Sarcosine is a prostate epigenetic modifier that elicits aberrant methylation patterns through the SAMe‐Dnmts axis
DNA hypermethylation is one of the most common epigenetic modifications in prostate cancer (PCa). Several studies have delineated sarcosine as a PCa oncometabolite that increases the migration of malignant prostate cells while decreasing their doubling time. Here, we show that incubation of prostate...
Autores principales: | Strmiska, Vladislav, Michalek, Petr, Lackova, Zuzana, Guran, Roman, Krizkova, Sona, Vanickova, Lucie, Zitka, Ondrej, Stiborova, Marie, Eckschlager, Tomas, Klejdus, Borivoj, Pacik, Dalibor, Tvrdikova, Eliska, Keil, Claudia, Haase, Hajo, Adam, Vojtech, Heger, Zbynek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487735/ https://www.ncbi.nlm.nih.gov/pubmed/30628163 http://dx.doi.org/10.1002/1878-0261.12439 |
Ejemplares similares
-
Identification of Sarcosine as a Target Molecule for the Canine Olfactory Detection of Prostate Carcinoma
por: Pacik, Dalibor, et al.
Publicado: (2018) -
Post‐treatment urinary sarcosine as a predictor of recurrent relapses in patients with prostate cancer
por: Gumulec, Jaromir, et al.
Publicado: (2018) -
Sarcosine Up-Regulates Expression of Genes Involved in Cell Cycle Progression of Metastatic Models of Prostate Cancer
por: Heger, Zbynek, et al.
Publicado: (2016) -
Sarcosine as a Potential Prostate Cancer Biomarker—A Review
por: Cernei, Natalia, et al.
Publicado: (2013) -
MALDI MSI of MeLiM melanoma: Searching for differences in protein profiles
por: Guran, Roman, et al.
Publicado: (2017)